| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5599450 | Atherosclerosis | 2016 | 41 Pages |
Abstract
Serum ALT could successfully reclassify about 9% of the population with type 2 diabetes across the CHD-affected and CHD-free categories. Overall, our findings demonstrate a complex and nonlinear relationship for the risk of future CVD by baseline serum ALT levels in patients with type 2 diabetes. Further studies are warranted to confirm whether this complex association could be translated into a clearly visible U or J-shaped figure.
Keywords
GGTWHRQUICKIA1cSBPWHtRDBPFPGFRSCHDHDL-CALTLDL-CHOMA-IRHOMA-βFPIγ-Glutamyl transferaseASTAspartate aminotransferaseAlanine aminotransferaseserum alanine aminotransferaseAlkaline phosphatasehomeostasis model assessment of insulin resistancefasting plasma insulincardiovascular diseaseCardiovascular diseasesCoronary heart diseasesnon-alcoholic fatty liver diseaseType 2 diabetesCVDbody mass indexBMIquantitative insulin sensitivity check indexdiastolic blood pressuresystolic blood pressureFasting plasma glucosehigh-density lipoprotein cholesterolWaist-to-height ratiowaist-to-hip ratioFramingham risk scoreHemoglobin A1cquartileLow-density lipoprotein cholesterol
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mohsen Afarideh, Zahra Aryan, Alireza Ghajar, Sina Noshad, Manouchehr Nakhjavani, Usman Baber, Jeffrey I. Mechanick, Alireza Esteghamati,